Susquehanna International Group
LPCN icon

Susquehanna International Group’s Lipocine LPCN Stock Holding History

Susquehanna International Group’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-87,100
Closed -$240K – 12831
2023
Q4 		$240K Sell
87,100
-100
-0.1% -$265 ﹤0.01% 10307
2023
Q3 		$256K Hold
87,200
– – ﹤0.01% 9691
2023
Q2 		$436K Buy
87,200
+81,976
+1,569% +$386K ﹤0.01% 8630
2023
Q1 		$28.4K Sell
5,224
-16,694
-76% -$129K ﹤0.01% 11934
2022
Q4 		$149K Sell
21,918
-135
-0.6% -$984 ﹤0.01% 10497
2022
Q3 		$169K Sell
22,053
-2,265
-9% -$25.3K ﹤0.01% 11081
2022
Q2 		$331K Sell
24,318
-6,129
-20% -$95.5K ﹤0.01% 9311
2022
Q1 		$709K Buy
30,447
+15,212
+100% +$318K ﹤0.01% 8049
2021
Q4 		$256K Sell
15,235
-6,977
-31% -$130K ﹤0.01% 10864
2021
Q3 		$412K Sell
22,212
-9,888
-31% -$218K ﹤0.01% 9857
2021
Q2 		$764K Sell
32,100
-11,412
-26% -$268K ﹤0.01% 8504
2021
Q1 		$1.12M Buy
43,512
+37,724
+652% +$1.09M ﹤0.01% 7453
2020
Q4 		$134K Sell
5,788
-18,471
-76% -$445K ﹤0.01% 10321
2020
Q3 		$581K Buy
+24,259
New +$644K ﹤0.01% 7367
2018
Q1 		– Sell
-2,924
Closed -$171K – 9801
2017
Q4 		$171K Buy
2,924
+2,218
+314% +$138K ﹤0.01% 8404
2017
Q3 		$48K Sell
706
-2,106
-75% -$152K ﹤0.01% 8547
2017
Q2 		$192K Buy
2,812
+1,394
+98% +$90.9K ﹤0.01% 8326
2017
Q1 		$94K Buy
1,418
+671
+90% +$43.5K ﹤0.01% 8416
2016
Q4 		$47K Sell
747
-412
-36% -$26.1K ﹤0.01% 9301
2016
Q3 		$88K Sell
1,159
-5,253
-82% -$325K ﹤0.01% 7987
2016
Q2 		$331K Buy
6,412
+5,506
+608% +$853K ﹤0.01% 6795
2016
Q1 		$156K Buy
906
+65
+8% +$11.1K ﹤0.01% 8180
2015
Q4 		$185K Buy
+841
New +$176K ﹤0.01% 8491

Other funds holding LPCN

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Susquehanna International Group's LPCN Position: Q1 2026 in Review

Susquehanna International Group reduced its Lipocine (LPCN) stake by 0% in Q1 2026, selling an estimated $9 and leaving 24,908 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #11717.

Susquehanna International Group first reported a position in LPCN in Q4 2015 and has held it in 31 quarters since. The position peaked at $700K in Q1 2016. 47 funds tracked by Wall St. Rank hold LPCN as of Q1 2026.

  • Susquehanna International Group held 24,908 shares of Lipocine worth $199K as of Q1 2026.
  • Susquehanna International Group sold 1 Lipocine share in Q1 2026, an estimated $9.
  • Lipocine made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11717 holding.
  • Susquehanna International Group first reported a position in Lipocine in Q4 2015 and has held it in 31 quarters since.
  • Susquehanna International Group's Lipocine position peaked at $700K in Q1 2016.
  • 47 funds tracked by Wall St. Rank held Lipocine as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.